Super Bowl, Novartis and breast cancer

Hailee Steinfeld's 'bucket list' Super Bowl commercial raises breast cancer awareness
Hailee Steinfeld is teaming up with Novartis to raise awareness about breast cancer with an empowering Super Bowl 59 commercial.
Novartis' first Super Bowl ad aims to 'create a movement' with breast cancer awareness blitz
To direct more attention toward the importance of regular breast cancer screenings, Novartis is taking to one of television’s biggest stages. | To direct more attention toward the importance of regular breast cancer screenings,
Novartis taps Hailee Steinfeld, Wanda Sykes for breast cancer Super Bowl ad
In addition to the partnership with Steinfeld and Sykes, Novartis is collaborating on awareness efforts and advocacy events with organizations like the Susan G. Komen, Living Beyond Breast Cancer, TOUCH (The Black Breast Cancer Alliance) and Breastcancer.org.
Hailee Steinfeld Reflects on 'Bucket List Moment' Starring in 'Empowering' First Super Bowl Ad (Exclusive)
I don't think there is one that I would feel as proud and as honored to be a part of as I do with this commercial,' Steinfeld exclusively told Parade ahead of the Super Bowl.
Novartis will make its Super Bowl debut with a breast cancer awareness ad
Pharmaceutical company Novartis will make its Super Bowl debut with a 60-second spot highlighting breast cancer awareness.
Sykes, Steinfeld, Breasts Star In Novartis Super Bowl Debut
"An attention-grabbing call to prioritize breast health," includes a focus on cheerleaders' and Hailee Steinfeld's breasts, with cut-in to cancer survivor Wanda Sykes.
Novartis, MSN Pharma agree to dismiss Kisqali patent lawsuit
Novartis (NYSE:NVS) and MSN Pharmaceuticals have reached agreement in a Delaware federal court to dismiss patent litigation ...
AbbVie Vs. Novartis: Which Has The Technical Edge Before Q4 Earnings?
AbbVie and Novartis to report Q4 earnings. AbbVie in stagnating trend, Novartis bullish. Breakdown of technical charts. Novartis has advantage, investors watch for post-earnings movement.
Novartis's SWOT analysis: pharma giant's stock faces pipeline and pricing pressures
Novartis AG (NYSE:NVS), a global healthcare company valued at over $206 billion, has undergone significant transformation in recent years, focusing its efforts on becoming a pure-play pharmaceutical ...
Novartis Expected to Post Higher Profit, Sales -- Earnings Preview
SALES FORECAST: Novartis's sales are forecast at $12.78 billion, according to analysts' estimates compiled by Visible Alpha. This compares with $11.42 billion the year before. Shares rose 5.1% over ...
BioPharma Dive2d
Rival radiopharma drug to Novartis’ Lutathera succeeds in trial, ITM says
ITM's lutetium-containing therapy extended progression-free survival versus everolimus in patients with a specific kind of ...
IPWatchdog1d
An Enablement Defense is Disabled by the Federal Circuit
In Novartis Pharms. Corp. v. Torrent Pharma Inc., the U. S. Court of Appeals for the Federal Circuit shut down efforts to market a generic version of the heart disease drug ENTRESTO which is sold ...
U.S. FDA nod for Natco Pharma’s generic of Novartis drug
Natco Pharma receives FDA approval for Everolimus tablets, launching generic version of Afinitor Disperz in U.S. market.
Early detection is a game changer: Novartis makes bold play to prioritize breast health and inspire a new wave of breast cancer screenings
Novartis, a global leader in breast cancer care, today announced the launch of the "Your Attention, Please" campaign, which ...